Current Molecular Pharmacology


Michael Kahn
(16435 citations)
Beckman Research Institute
City of Hope
Duarte, CA 91010-3000

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 4 Issue: 1, January

Neurosteroids and Hepatic Encephalopathy: An Update on Possible Pathophysiologic Mechanisms

Volume:4   Issue: 1
Pp: 1-13
Samir Ahboucha
DOI: 10.2174/1874467211104010001
Published on: 01 March, 2012

The Therapeutic Potential of the Wnt Signaling Pathway in Bone Disorders

Volume:4   Issue: 1
Pp: 14-25
Eric R. Wagner, Gaohui Zhu, Bing-Qiang Zhang, Qing Luo, Qiong Shi, Enyi Huang, Yanhong Gao, Jian-Li Gao, Stephanie H. Kim, Farbod Rastegar, Ke Yang, Bai-Cheng He, Liang Chen, Guo-Wei Zuo, Yang Bi, Yuxi Su, Jinyong Luo, Xiaoji Luo, Jiayi Huang, Zhong-Liang Deng, Russell R. Reid, Hue H. Luu, Rex C. Haydon and Tong-Chuan He
DOI: 10.2174/1874467211104010014
Published on: 01 March, 2012

Apoptosis Induction by Thalidomide: Critical for Limb Teratogenicity but Therapeutic Potential in Idiopathic Pulmonary Fibrosis?

Volume:4   Issue: 1
Pp: 26-61
Jurgen Knobloch, David Jungck and Andrea Koch
DOI: 10.2174/1874467211104010026
Published on: 01 March, 2012

HIF-1 as a Target for Cancer Chemotherapy, Chemosensitization and Chemoprevention

Volume:4   Issue: 1
Pp: 62-77
Elena Monti and Marzia B. Gariboldi
DOI: 10.2174/1874467211104010062
Published on: 01 March, 2012